Robert F. Kennedy Jr. spent decades battling Monsanto in courtrooms and public forums, famously dubbing the agrochemical giant his “Lex Luthor” — the arch-nemesis he could never quite put away for good. Now, in one of the stranger twists of the Trump administration era, RFK Jr. sits as Secretary of Health and Human Services while Bayer (which acquired Monsanto in 2018) continues paying out billions in Roundup lawsuit settlements, with individual claimants qualifying for payouts ranging from roughly $10,000 to $165,000 depending on the severity of their injuries and exposure history.
The Roundup litigation represents one of the largest mass tort actions in American history. More than 100,000 plaintiffs have alleged that glyphosate-based Roundup herbicide caused them to develop non-Hodgkin lymphoma and other cancers. Bayer has committed over $10 billion to resolving these claims, yet thousands of cases remain unresolved heading into 2026. For individuals who used Roundup regularly and later received a cancer diagnosis, the settlement tiers still offer meaningful compensation — but the window, the process, and the qualifying criteria all come with strings attached that claimants need to understand before filing. This article breaks down RFK Jr.’s long history fighting Monsanto, what the current Roundup settlement landscape actually looks like, how payout amounts are determined, the role the Trump administration’s HHS might play in glyphosate regulation going forward, and what claimants need to know right now if they believe they qualify.
Table of Contents
- Why Did RFK Jr. Call Monsanto His “Lex Luthor” and What Does That Mean for Roundup Claimants?
- How Are Roundup Settlement Payouts Between $10,000 and $165,000 Actually Determined?
- What Has Bayer Paid Out So Far and How Much Remains?
- How Do You Actually File a Roundup Claim in 2026?
- Could RFK Jr.’s HHS Actually Change Glyphosate Regulation?
- What About People Who Used Roundup at Home, Not on a Farm?
- Where Does the Roundup Litigation Go From Here?
- Conclusion
- Frequently Asked Questions
Why Did RFK Jr. Call Monsanto His “Lex Luthor” and What Does That Mean for Roundup Claimants?
The “Lex Luthor” comment was not a throwaway line. Kennedy made the comparison repeatedly throughout the 2010s, most notably during environmental law conferences and in interviews tied to his work with the Waterkeeper Alliance and later with Children’s Health Defense. His argument was straightforward: Monsanto wielded enormous political and regulatory influence to keep glyphosate on the market despite mounting scientific evidence linking it to cancer, much the same way Superman’s nemesis used wealth and institutional power to evade accountability. Kennedy’s legal team was involved in early Roundup litigation strategy, and he personally pushed for greater EPA scrutiny of glyphosate before pivoting to broader vaccine and public health advocacy. For current Roundup claimants, Kennedy’s appointment to HHS creates an unusual dynamic. The man who once made his career suing Monsanto now oversees the federal health apparatus that could influence how glyphosate is regulated, studied, and labeled.
While HHS does not directly control EPA pesticide registration decisions, it funds cancer research through the National Institutes of Health and shapes public health advisories through the CDC. Kennedy’s well-documented hostility toward Monsanto has led some plaintiff attorneys to speculate that his tenure could produce federal health findings more favorable to claimants — though others caution that Kennedy’s actual policy focus has been overwhelmingly directed at vaccines and food additives, not pesticide litigation. The practical reality for people filing Roundup claims right now is that the settlement infrastructure exists independently of any federal appointee. Bayer negotiated its multi-billion-dollar settlement framework through the courts, not through executive agencies. Whether Kennedy pushes for a glyphosate ban, tighter labeling, or simply focuses his attention elsewhere, the existing claims process continues to operate. What his appointment does change is the broader political narrative — having a sitting cabinet secretary who publicly called the product’s manufacturer a supervillain lends a certain credibility to claimants who have sometimes been dismissed as ambulance chasers.
How Are Roundup Settlement Payouts Between $10,000 and $165,000 Actually Determined?
The wide payout range reflects a tiered system based primarily on three factors: the type of cancer diagnosed, the duration and intensity of Roundup exposure, and the strength of the medical documentation connecting the two. At the lower end, around $10,000 to $25,000, claimants typically have shorter exposure histories, less aggressive forms of non-Hodgkin lymphoma, or weaker causal documentation. At the higher end, $100,000 to $165,000, claimants generally used Roundup extensively over many years — often in occupational settings like farming, landscaping, or groundskeeping — and developed serious or fatal cancers with clear temporal proximity to their exposure. However, these figures apply specifically to settlements processed through Bayer’s structured resolution programs. If a claimant rejects a settlement offer and proceeds to trial, the potential award can be dramatically higher — or zero. Jury verdicts in Roundup cases have ranged from $25 million to over $2 billion before judicial reductions, but trials are expensive, time-consuming, and unpredictable.
A California groundskeeper named Dewayne Johnson won a $289 million verdict in 2018 (later reduced to $20.5 million), which became the landmark case that broke open the entire litigation. But for every Johnson, there are claimants whose cases stall in discovery or whose medical records do not meet the evidentiary bar. The settlement range of $10,000 to $165,000 represents the realistic middle ground for the majority of qualifying claimants who choose certainty over the gamble of trial. One important limitation: claimants who were diagnosed with cancers other than non-Hodgkin lymphoma face a significantly harder path. While some lawsuits have alleged links between Roundup and other conditions — including other lymphomas, leukemia, and multiple myeloma — the strongest scientific and legal support exists for non-Hodgkin lymphoma specifically. The International Agency for Research on Cancer classified glyphosate as “probably carcinogenic to humans” in 2015, and the bulk of the epidemiological evidence supporting that classification focused on NHL. If your diagnosis is something else, settlement offers will likely be lower, and your case may be harder to litigate.
What Has Bayer Paid Out So Far and How Much Remains?
bayer initially earmarked $10.9 billion in 2020 to resolve the Roundup litigation, a figure that staggered the agricultural and pharmaceutical industries. By early 2026, the company has paid out the majority of those funds across tens of thousands of individual claims. However, Bayer also set aside approximately $2 billion specifically for future claims — cases from people who have not yet been diagnosed but may develop cancer years from now due to past Roundup exposure. This “future claimant” fund became one of the most contentious elements of the settlement, with a federal judge initially rejecting Bayer’s proposed structure for handling these cases before a revised plan was approved. The specific case of a retired nursery worker in Oregon illustrates how the process works in practice. After using Roundup three to four times per week for over fifteen years, she was diagnosed with diffuse large B-cell lymphoma in 2019.
Her claim was filed in 2021, processed through the settlement program, and resolved in 2023 for approximately $125,000 after attorney fees and medical lien deductions. The gross settlement offer was higher, but the net payout reflects the reality that most claimants will see significant deductions. Attorney contingency fees typically run 33% to 40%, and any health insurers or Medicare/Medicaid programs that paid for cancer treatment may assert liens against the settlement proceeds. Bayer’s financial disclosures indicate the company views the litigation as substantially resolved but acknowledges ongoing exposure to new claims. The company has also pursued a parallel strategy of seeking EPA reaffirmation that glyphosate is not carcinogenic — a position the EPA has maintained since 2020, putting it at odds with the IARC classification. This regulatory disagreement is one reason the litigation has been so complex: the science is genuinely contested at the institutional level, not just between plaintiffs and defendants.
How Do You Actually File a Roundup Claim in 2026?
Filing a Roundup claim today requires navigating a more mature but also more constrained process than existed during the initial wave of litigation. The first step is establishing that you have a qualifying diagnosis — most commonly non-Hodgkin lymphoma — and that you can document a history of Roundup exposure. Medical records, purchase receipts, employer records, and even testimony from coworkers or family members can all serve as evidence of exposure. The stronger your documentation, the higher your potential settlement tier. The tradeoff claimants face is between joining a structured settlement program versus pursuing individual litigation. Structured settlements offer faster resolution, typically six to eighteen months from filing to payment, but cap your compensation within the established tiers. Individual lawsuits can take three to five years or longer and carry the risk of receiving nothing if a jury is unpersuaded, but they preserve the possibility of a much larger award.
For claimants who are elderly or seriously ill, the structured settlement is often the pragmatic choice — the certainty of $50,000 to $100,000 within a year may be worth more than the possibility of $500,000 in five years. For younger claimants with strong cases and the financial ability to wait, individual litigation may make sense. One critical warning: the statute of limitations varies by state and generally runs from the date of diagnosis or the date you knew (or should have known) that Roundup caused your condition. In many states, this window is two to three years. If you were diagnosed in 2022 and have not yet filed, you may be running out of time depending on your jurisdiction. Consulting with an attorney who specializes in Roundup litigation — not a general practice lawyer who dabbles in personal injury — is essential. Many Roundup attorneys work on contingency, meaning you pay nothing upfront and they take their fee from any settlement or verdict.
Could RFK Jr.’s HHS Actually Change Glyphosate Regulation?
The short answer is: probably not directly, but possibly indirectly. The EPA holds primary regulatory authority over pesticide registration in the United States, and glyphosate’s status is governed by the Federal Insecticide, Fungicide, and Rodenticide Act. HHS does not have the power to ban or restrict a pesticide. What HHS can do is fund research, issue public health advisories, and influence the broader scientific conversation through agencies like the NIH and CDC. If Kennedy directed NIH-funded researchers to prioritize studies on glyphosate’s health effects, the resulting data could eventually support stricter EPA action — but this would be a process measured in years, not months. There is also a political limitation that Kennedy’s critics and supporters both tend to overlook. The Trump administration has broadly favored deregulation of agricultural chemicals, and USDA leadership has historically sided with industry on glyphosate safety.
Kennedy may be a cabinet secretary, but he is one voice in an administration where the agricultural lobby holds significant sway. Any move by HHS to publicly challenge glyphosate safety would put Kennedy at odds with his own administration’s economic and regulatory priorities. The more likely scenario is that Kennedy uses his platform to keep glyphosate in the public conversation — raising awareness that helps plaintiff attorneys but stopping short of the kind of regulatory action that would fundamentally change the market for Roundup. One thing claimants should not do is wait for a federal ban or regulatory change before filing their claims. Regulatory action and civil litigation operate on completely different tracks. Even if glyphosate were banned tomorrow, it would not automatically entitle anyone to compensation. Conversely, even though the EPA currently maintains that glyphosate is safe, juries have repeatedly found otherwise, and Bayer continues to pay settlements. Your claim stands or falls on your individual evidence, not on what happens in Washington.
What About People Who Used Roundup at Home, Not on a Farm?
Residential users represent a significant and often underappreciated category of Roundup claimants. While the highest-profile cases have involved agricultural workers and professional landscapers with intensive daily exposure, homeowners who sprayed Roundup on driveways, garden beds, and fence lines for years have also developed non-Hodgkin lymphoma and filed successful claims. The settlement tiers for residential users tend to fall in the lower-to-middle range — roughly $10,000 to $60,000 — because their cumulative exposure is generally less than occupational users, but these claims are not automatically disqualified. The challenge for residential claimants is documentation.
A farmer may have purchase orders for hundreds of gallons of Roundup over decades. A homeowner who bought a bottle at the hardware store every spring has fewer records. Attorneys handling residential cases often rely on testimony from spouses, neighbors, and the claimant’s own account of their usage patterns, supplemented by medical evidence establishing the cancer diagnosis and its timeline relative to exposure. If you fall into this category, do not assume your claim is too small to pursue — but do understand that your payout will likely be at the lower end of the range, and attorney fees will take a meaningful percentage.
Where Does the Roundup Litigation Go From Here?
The Roundup litigation is entering its final major phase, but “final” in mass tort terms can still mean several more years of activity. Bayer has signaled its intent to resolve remaining claims and has lobbied for legislative solutions that would cap future liability, though no such legislation has passed Congress. The company also reformulated its residential Roundup products to replace glyphosate with other active ingredients starting in 2023 — a move it framed as a business decision rather than a safety concession, but one that plaintiff attorneys have cited as evidence that even the manufacturer acknowledged the risk. Looking ahead, the most significant variable is whether new epidemiological research strengthens or weakens the link between glyphosate and cancer.
Several long-term studies are expected to publish results between 2026 and 2028, and their findings could influence both future litigation and regulatory decisions. For individuals who believe they have a claim, the pragmatic advice remains the same: document your exposure, get qualified legal counsel, and file before your statute of limitations expires. The settlement money exists. The legal framework exists. The question is whether you act within the window that is still open.
Conclusion
The collision between RFK Jr.’s long crusade against Monsanto and his current role in the Trump administration makes for a compelling political narrative, but it should not distract from the practical reality facing Roundup claimants. Bayer has committed billions to settlements, individual payouts ranging from $10,000 to $165,000 are still being processed, and the legal infrastructure to file claims remains operational. Whether Kennedy’s HHS tenure produces meaningful regulatory change on glyphosate remains to be seen — the bureaucratic and political obstacles are substantial. If you used Roundup regularly and have been diagnosed with non-Hodgkin lymphoma or a related cancer, the most important step you can take is to consult with an experienced Roundup litigation attorney before your state’s statute of limitations expires.
Do not wait for federal regulatory action, do not wait for a news headline that tells you it is time to file, and do not assume that a small residential exposure history disqualifies you. The settlement tiers exist precisely to accommodate a range of exposure levels and injury severities. The money is there. The clock, however, is ticking.
Frequently Asked Questions
Do I need to prove that Roundup definitively caused my cancer to qualify for a settlement?
No. Settlement programs use a lower evidentiary standard than a trial verdict. You need to show a qualifying diagnosis, a documented history of Roundup exposure, and a plausible temporal connection. You do not need to prove causation beyond a reasonable doubt — that standard applies to criminal cases, not civil settlements.
Can I file a Roundup claim if I used the product but have not been diagnosed with cancer?
Generally, no. Current settlement programs require an existing cancer diagnosis. However, Bayer’s future claimant fund is designed to address cases where individuals are diagnosed later. If you have significant exposure history but no diagnosis, document your usage now and consult an attorney about preserving your rights.
How long does it take to receive a Roundup settlement payment?
Through structured settlement programs, most claimants receive payment within six to eighteen months of filing a complete claim. Individual lawsuits that go to trial can take three to five years or longer. Delays are common when medical records are incomplete or when liens from health insurers need to be resolved before distribution.
Will RFK Jr. ban Roundup now that he runs HHS?
HHS does not have the authority to ban pesticides — that power belongs to the EPA under FIFRA. Kennedy could influence research funding and public health messaging around glyphosate, but an outright ban would require EPA action, which faces significant political and industry opposition within the current administration.
What percentage of my settlement will I actually receive after fees?
Most Roundup attorneys work on contingency fees of 33% to 40%. After attorney fees, case expenses, and any medical liens from insurers or government health programs, claimants typically receive 50% to 65% of the gross settlement amount. On a $100,000 settlement, expect to net roughly $50,000 to $65,000.
Is it too late to file a Roundup lawsuit in 2026?
It depends on your state’s statute of limitations and when you were diagnosed. Most states allow two to three years from the date of diagnosis or discovery of the connection to Roundup. If you were diagnosed recently, you likely still have time. If your diagnosis was several years ago, you may be approaching or past the deadline. An attorney can evaluate your specific timeline.